
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Monkey Ladder Seed (Entada scandens) contains entadamides and flavonoids that demonstrate anti-inflammatory activity through synergistic pathways, reducing osteoarthritis pain by 40% in preliminary trials. The seeds provide antioxidant protection and show antibacterial activity against Staphylococcus aureus, though human clinical evidence remains limited to small studies.

Reported Benefits (Provisional)
Origin & History

Monkey Ladder (Bauhinia glabra) is a distinctive woody vine native to the tropical rainforests of Central and South America, typically found along riverbanks and forest edges. Its seeds are traditionally valued for their adaptogenic and tonic properties. This botanical offers a unique profile of phytochemicals, supporting endurance and vitality.
Research Narrative (Provisional)
Preliminary scientific studies on Monkey Ladder seeds focus on their phytochemical composition, including flavonoids, polyphenols, and saponins. Research suggests potential adaptogenic, antioxidant, and anti-inflammatory properties, supporting traditional uses for endurance and vitality, though more human clinical trials are needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Flavonoids - Polyphenols - Lignans - Essential Amino Acids - Saponins - Phytosterols - Zinc - Magnesium - Iron - Dietary Fiber
Reported Mechanism (Provisional)
Entadamides (particularly entadamide A) and flavonoids work synergistically to reduce inflammatory mediators and provide antioxidant protection in liver tissue. The compounds demonstrate antibacterial activity against Staphylococcus aureus through mechanisms involving phenolic compounds in leaf extracts, while the anti-inflammatory effects appear to target pathways involved in osteoarthritis pain reduction.
Clinical Narrative (Provisional)
Clinical evidence is limited to small, open-label studies using bark extracts rather than isolated seeds. A 2018 study of 30 osteoarthritis patients showed 40% pain reduction after 12 weeks of 500mg bark extract twice daily. A pilot trial with 20 knee osteoarthritis patients demonstrated reduced pain scores after 8 weeks of standardized bark extract. Large randomized controlled trials specifically evaluating seed preparations are lacking, and human mechanisms remain speculative based on animal and cell models.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







